Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

Obama Admin Co-Owned mRNA Vax With Moderna—YEARS Before COVID! Docs prove NIH & Moderna signed a confidential vaccine deal in 2015—jointly owning mRNA coronavirus vax tech. 🔹 Tech handed to Dr. Ralph Baric (yes, that Baric). 🔹 "Frankenstein coronavirus" research in motion under Obama. So no, this was never...

162,998 görüntüleme • 11 ay önce •via X (Twitter)

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

"The [COVID] shots were coming from the DOD...They have a separate office [inside Moderna]. Only people with security clearance can go in that office. And [they] receive [the] active ingredients in bags. [Moderna doesn't] know what it is, [they] just mix it...and ship it out." Retired pharma R&D executive Sasha Latypova (sashalatypova.substack.com "Due Diligence and Art") describes for Neil Oliver (Neil Oliver) how the U.S. Department of Defense (DOD) is ultimately responsible for much of the design and production of the COVID injections. Latypova says in this clip that the Pentagon put on several press conferences "where [they discussed] that they have their own mRNA products" and notes that the department even has its own separate office inside of Moderna, which is only accessible to those with the right security clearance. Incredibly, Latypova notes that the DOD provides the active ingredients for the injections to Moderna "in bags," which are then mixed in with lipid nanoparticles and shipped out. Those who do the mixing at Moderna have no idea what's inside of the bags. "Clearly, this is a government vaccine," Latypova says. ---------------Partial transcription of clip-------------- "So yes, so the way this was done, ostensibly, they're saying HHS partnered with DOD, although, actually, they've been learning and figured out how why they partnered together. They partnered together to overcome their own respective limitations which was Legal limitations. Legal limitations established by Congress of what they can and cannot do. So to overcome those limitations, they combined their forces, HHS and DOD, to order mass order medical products and vaccines that were going to be distributed to the civilian population and would not be they would be under these EUA countermeasure frameworks, which absolves them of all regulatory requirements. And so separately, they couldn't do that. "So DoD could do it for themselves, but not for civilian population, not in mass. And for HHS to do that, it needed to go through regulatory approval, which this didn't. So they combined their forces. And then the Department of Defense gave this consortium, this public private consortium, dollars 50 billion dollars, just the first goal, to produce these shots. But the shots were coming from the DoD. So the DoD actually there are several Pentagon press releases or press conferences rather where they're discussing that they have their own product, their own mRNA product. "And so, and I'm also in touch with other, people who worked and currently work for Moderna. And they were saying, yeah, we have a separate office inside Moderna. This is in outside of Boston. They have a separate office, which is DOD only. Only people with security clearance can go in that office. And we receive active ingredient in bags. We don't know what it is, and we just mix it in with LNPs and ship it out. "DARPA and also NIH participated in this. So, specifically, NIH developed several vaccine candidates, transferred them to Moderna, the new product candidates, transferred them to Moderna right before 2020. There are documents for that too. And then as part of the R and D I also discussed this with RFK Jr. As part of the R and D program, which was very poorly done, but still there were some studies being done, NIH ran several studies several critical studies for Moderna. "So NIH themselves in their Vaccine Research Center ran those studies, gave reports to Moderna. And these reports have we still have very hard time to FOIA them. And it's in process. We're trying to FOIA them. But so and NIH also co owns investigational so there's an investigational number assigned to every new product in pharmaceutical R and D and FDA approval program. So NIH owns separate number for Moderna product in addition to Moderna owning another number. So there are two numbers for one product. One is owned by NIH. One is owned by Moderna. So clearly, this is a government vaccine."

Sense Receptor

146,297 görüntüleme • 1 yıl önce